DIANE CHUNG: Open Payments
NPI 1841773645 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,250 in 70 payments from 12 companies in 2025. Trend: 2023 $2,872 · 2024 $1,946 · 2025 $1,250
Food & beverage: $1,085Education: $165
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $342 |
| ABBVIE INC. | 17 | $271 |
| LEO Pharma Inc. | 7 | $171 |
| MAYNE PHARMA COMMERCIAL LLC | 16 | $141 |
| PFIZER INC. | 3 | $83 |
| GENZYME CORPORATION | 2 | $60 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $44 |
| Amgen Inc. | 2 | $38 |
| UCB, Inc. | 1 | $30 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $26 |
Products named: TREMFYA, RINVOQ, ADBRY, CIBINQO, SKYRIZI, DUPIXENT, Otezla, ANZUPGO.
Industry payments across CA — which companies pay providers there.
